← All stocks

Annexon, Inc.

ANNX Net buying
CIK 0001528115 #2555 in the set updated 17 Sep 2026
Bought (120 mo)
$67.24M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.16M
$129.58K on a plan · $2.39M straight out of an exercise
Sold at will
$633.58K
39 of 68 sales
Net
+$64.08M
+$66.61M against sales at will

By person

15 insiders · 110 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Satter Muneer A
Director
$43.81M (10)
+$43.81M
12,297,112
8.23%
$66.53M
+529.0%
Flynn James E
10% owner
$11.90M (2)
+$11.90M
1,617,828
1.08%
$8.75M
Bain Capital Life Sciences Investors, LLC entity
10% owner
$7.44M (2)
+$7.44M
8,943,554
5.99%
$48.38M
+65.6%
Clarus Lifesciences III, L.P.
10% owner
$3.40M (1)
+$3.40M
2,730,635
1.83%
$14.77M
Yednock Ted
EVP & CHIEF INNOVATION OFFICER
$1.51M (20) scheduled
−$1.51M
184,807
0.1237%
$999.81K
+213.8%
Love Douglas
PRESIDENT AND CEO
$146.81K (1)
$819.94K (14) scheduled
−$673.13K
351,554
0.2354%
$1.90M
+2,162%
Lew Jennifer
EVP & CHIEF FINANCIAL OFFICER
$34.00K (1)
$435.82K (16) scheduled
−$401.82K
170,700
0.1143%
$923.49K
+1,204%
Carson William H.
Director
$374.09K (18)
+$374.09K
78,405
0.0525%
$424.17K
Choi Jung
Director
$138.27K (1)
+$138.27K
33,000
0.0221%
$178.53K
Keswani Sanjay Chandru
EVP & Chief Medical Officer
$120.51K (1) scheduled
−$120.51K
12,500
0.0084%
$67.63K
Overdorf Michael
EVP & CHIEF BUSINESS OFFICER
$118.27K (11)
−$118.27K
182,625
0.1223%
$988.00K
+750.2%
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
$75.36K (3)
−$75.36K
180,093
0.1206%
$974.30K
+257.8%
Dananberg Jamie
CHIEF MEDICAL OFFICER
$74.92K (3)
−$74.92K
123,582
0.0827%
$668.58K
Redmile Group, LLC entity
10% owner
1,596,222
1.07%
$8.64M
Mattheakis Larry
EVP & Chief Scientific Officer
17,188
0.0115%
$92.99K
Insider
Date
Role
Action
Shares
Price
Amount
Yednock Ted
11 Jun 2026
EVP & CHIEF INNOVATION OFFICER
Exercised, kept
30,646
$1.85
$56.70K
Satter Muneer A
28 May 2026
Director
Buy indirect
613,497
$5.41
$3.32M
Carson William H.
11 May 2026
Director
Buy
8,000
$5.78
$46.24K
Carson William H.
10 Apr 2026
Director
Buy
8,000
$6.20
$49.60K
Carson William H.
10 Mar 2026
Director
Buy
8,000
$5.67
$45.36K
Lew Jennifer
2 Mar 2026
EVP & CHIEF FINANCIAL OFFICER
Sell
5,565
$5.42
$30.16K
ARTIS DEAN RICHARD
2 Mar 2026
EVP & CHIEF SCIENTIFIC OFFICER
Sell
5,894
$5.43
$32.00K
Yednock Ted
2 Mar 2026
EVP & CHIEF INNOVATION OFFICER
Sell
5,566
$5.42
$30.17K
Overdorf Michael
2 Mar 2026
EVP & CHIEF BUSINESS OFFICER
Sell
4,339
$5.42
$23.52K
Dananberg Jamie
2 Mar 2026
CHIEF MEDICAL OFFICER
Sell
5,820
$5.43
$31.60K
Overdorf Michael
18 Feb 2026
EVP & CHIEF BUSINESS OFFICER
Sell
6,225
$5.10
$31.75K
Yednock Ted
18 Feb 2026
EVP & CHIEF INNOVATION OFFICER
Sell
7,857
$5.11
$40.15K
ARTIS DEAN RICHARD
18 Feb 2026
EVP & CHIEF SCIENTIFIC OFFICER
Sell
5,290
$5.10
$26.98K
Lew Jennifer
18 Feb 2026
EVP & CHIEF FINANCIAL OFFICER
Sell
7,851
$5.11
$40.12K
Dananberg Jamie
18 Feb 2026
CHIEF MEDICAL OFFICER
Sell
5,290
$5.10
$26.98K
Carson William H.
30 Dec 2025
Director
Buy
4,115
$5.02
$20.66K
Carson William H.
1 Dec 2025
Director
Buy
4,115
$4.47
$18.39K
Choi Jung
1 Dec 2025
Director
Buy indirect
33,000
$4.19
$138.27K
Satter Muneer A
21 Nov 2025
Director
Buy indirect
422,613
$4.28
$1.81M
Satter Muneer A
20 Nov 2025
Director
Buy indirect
400,000
$4.48
$1.79M
Satter Muneer A
19 Nov 2025
Director
Buy indirect
500,000
$3.94
$1.97M
Satter Muneer A
18 Nov 2025
Director
Buy indirect
500,000
$3.18
$1.59M
Satter Muneer A
17 Nov 2025
Director
Buy indirect
500,000
$2.99
$1.50M
Carson William H.
30 Oct 2025
Director
Buy
4,115
$3.17
$13.04K
Carson William H.
30 Sep 2025
Director
Buy
4,115
$3.05
$12.55K
Carson William H.
2 Sep 2025
Director
Buy
4,115
$2.09
$8.60K
Carson William H.
30 Jul 2025
Director
Buy
4,115
$2.43
$10.00K
Overdorf Michael
14 Jul 2025
EVP & CHIEF BUSINESS OFFICER
Sell
853
$2.61
$2.23K
Lew Jennifer
14 Jul 2025
EVP & CHIEF FINANCIAL OFFICER
Sell
1,117
$2.58
$2.88K
Yednock Ted
14 Jul 2025
EVP & CHIEF INNOVATION OFFICER
Sell
1,116
$2.58
$2.88K
Carson William H.
30 Jun 2025
Director
Buy
4,115
$2.46
$10.12K
Lew Jennifer
18 Feb 2025
EVP & CHIEF FINANCIAL OFFICER
Sell
6,912
$2.92
$20.18K
Overdorf Michael
18 Feb 2025
EVP & CHIEF BUSINESS OFFICER
Sell
6,618
$2.95
$19.52K
Yednock Ted
18 Feb 2025
EVP & CHIEF INNOVATION OFFICER
Sell
8,345
$2.91
$24.28K
ARTIS DEAN RICHARD
18 Feb 2025
EVP & CHIEF SCIENTIFIC OFFICER
Sell
5,515
$2.97
$16.38K
Dananberg Jamie
18 Feb 2025
CHIEF MEDICAL OFFICER
Sell
5,521
$2.96
$16.34K
Yednock Ted
13 Feb 2025
EVP & CHIEF INNOVATION OFFICER
Sell
1,783
$2.99
$5.33K
Overdorf Michael
13 Feb 2025
EVP & CHIEF BUSINESS OFFICER
Sell
1,425
$2.99
$4.26K
Lew Jennifer
13 Feb 2025
EVP & CHIEF FINANCIAL OFFICER
Sell
1,786
$2.98
$5.32K
Love Douglas
13 Feb 2025
PRESIDENT AND CEO
Sell
5,021
$2.95
$14.81K
Love Douglas
6 Jan 2025
PRESIDENT AND CEO
Exercised, kept
37,994
$1.41
$53.56K
Carson William H.
2 Dec 2024
Director
Buy
3,200
$5.33
$17.06K
Love Douglas
30 Oct 2024
PRESIDENT AND CEO
Exercised, kept
36,050
$1.85
$66.70K
Love Douglas
30 Oct 2024
PRESIDENT AND CEO
Exercised, kept
78,399
$1.85
$145.05K
Yednock Ted
15 Oct 2024
EVP & CHIEF INNOVATION OFFICER
Sold after exercise
5,408
$7.41
$40.07K
Carson William H.
1 Oct 2024
Director
Buy
3,200
$5.97
$19.10K
Yednock Ted
19 Sep 2024
EVP & CHIEF INNOVATION OFFICER
Sold on a plan indirect
4,500
$7.10
$31.95K
Yednock Ted
12 Sep 2024
EVP & CHIEF INNOVATION OFFICER
Sold on a plan indirect
5,500
$6.16
$33.88K
Yednock Ted
5 Sep 2024
EVP & CHIEF INNOVATION OFFICER
Sold on a plan indirect
5,500
$5.64
$31.02K
Carson William H.
3 Sep 2024
Director
Buy
3,200
$5.48
$17.54K
Yednock Ted
29 Aug 2024
EVP & CHIEF INNOVATION OFFICER
Sold on a plan indirect
5,500
$5.95
$32.73K
Carson William H.
1 Aug 2024
Director
Buy
3,200
$6.24
$19.97K
Yednock Ted
15 Jul 2024
EVP & CHIEF INNOVATION OFFICER
Sell
1,106
$6.02
$6.66K
Lew Jennifer
15 Jul 2024
EVP & CHIEF FINANCIAL OFFICER
Sell
1,104
$6.03
$6.66K
Overdorf Michael
15 Jul 2024
EVP & CHIEF BUSINESS OFFICER
Sell
784
$6.02
$4.72K
Carson William H.
1 Jul 2024
Director
Buy
3,200
$5.00
$16.00K
Carson William H.
3 Jun 2024
Director
Buy
3,200
$4.83
$15.46K
Carson William H.
1 May 2024
Director
Buy
3,200
$4.68
$14.98K
Carson William H.
8 Apr 2024
Director
Buy
3,200
$6.07
$19.41K
Overdorf Michael
20 Feb 2024
EVP & CHIEF BUSINESS OFFICER
Sell
1,951
$5.48
$10.69K
Yednock Ted
20 Feb 2024
EVP & CHIEF INNOVATION OFFICER
Sell
2,604
$5.51
$14.35K
Lew Jennifer
20 Feb 2024
EVP & CHIEF FINANCIAL OFFICER
Sell
2,593
$5.53
$14.34K
Yednock Ted
12 Feb 2024
EVP & CHIEF INNOVATION OFFICER
Sell
1,810
$5.54
$10.03K
Lew Jennifer
12 Feb 2024
EVP & CHIEF FINANCIAL OFFICER
Sell
1,809
$5.54
$10.02K
Love Douglas
12 Feb 2024
PRESIDENT AND CEO
Sell
5,782
$5.54
$32.03K
Overdorf Michael
12 Feb 2024
EVP & CHIEF BUSINESS OFFICER
Sell
1,349
$5.53
$7.46K
Yednock Ted
27 Dec 2023
EVP & Chief Innovation Officer
Sold after exercise
21,000
$4.52
$94.97K
Satter Muneer A
26 Dec 2023
Director
Buy indirect
350,000
$2.88
$1.01M
Lew Jennifer
11 Jul 2023
EVP & Chief Financial Officer
Sell
1,057
$3.84
$4.05K
Overdorf Michael
11 Jul 2023
EVP & Chief Business Officer
Sell
978
$3.84
$3.75K
Bain Capital Life Sciences Investors, LLC
25 May 2023
10% owner
Buy indirect
300,000
$2.13
$639.72K
Love Douglas
15 Feb 2023
President & CEO
Sell
6,571
$5.87
$38.56K
Lew Jennifer
14 Feb 2023
EVP & Chief Financial Officer
Sell
166
$6.30
$1.05K
Overdorf Michael
14 Feb 2023
EVP & Chief Business Officer
Sell
144
$6.30
$907.10
Lew Jennifer
13 Feb 2023
EVP & Chief Financial Officer
Sell
1,742
$6.31
$10.99K
Overdorf Michael
13 Feb 2023
EVP & Chief Business Officer
Sell
1,501
$6.30
$9.46K
Satter Muneer A
10 Feb 2023
Director
Buy indirect
2,647,058
$6.80
$18.00M
Satter Muneer A
7 Jul 2022
Director
Buy indirect
2,453,988
$3.84
$9.42M
Love Douglas
14 Apr 2022
President & CEO
Buy
60,000
$2.45
$146.81K
Love Douglas
11 Nov 2021
President & CEO
Exercised, kept
30,000
$1.85
$55.50K
Love Douglas
11 Nov 2021
President & CEO
Exercised, kept
70,942
$1.41
$100.00K
Love Douglas
16 Sep 2021
President & CEO
Sold after exercise
7,500
$22.05
$165.34K
Lew Jennifer
13 Sep 2021
EVP & Chief Financial Officer
Sold after exercise
3,500
$20.01
$70.03K
Yednock Ted
13 Sep 2021
EVP & Chief Scientific Officer
Sold after exercise
16,190
$20.00
$323.86K
Love Douglas
8 Jun 2021
President & CEO
Sold after exercise
3,750
$22.55
$84.56K
Love Douglas
7 Jun 2021
President & CEO
Sold after exercise
3,750
$22.31
$83.67K
Yednock Ted
3 Jun 2021
EVP & Chief Scientific Officer
Sold after exercise
2,184
$21.72
$47.44K
Yednock Ted
3 Jun 2021
EVP & Chief Scientific Officer
Sold after exercise
12,816
$21.45
$274.88K
Lew Jennifer
27 May 2021
EVP & Chief Financial Officer
Sold after exercise
3,500
$22.24
$77.84K
Love Douglas
1 Apr 2021
President & CEO
Sold after exercise
300
$28.01
$8.40K
Love Douglas
1 Apr 2021
President & CEO
Sold after exercise
200
$28.19
$5.64K
Love Douglas
31 Mar 2021
President & CEO
Sold after exercise
7,102
$28.11
$199.62K
Love Douglas
30 Mar 2021
President & CEO
Sold after exercise
1,850
$24.78
$45.85K
Love Douglas
30 Mar 2021
President & CEO
Sold after exercise
1,900
$24.27
$46.12K
Love Douglas
29 Mar 2021
President & CEO
Sold after exercise
300
$27.24
$8.17K
Love Douglas
29 Mar 2021
President & CEO
Sold after exercise
600
$26.42
$15.85K
Love Douglas
29 Mar 2021
President & CEO
Sold after exercise
2,850
$25.02
$71.31K
Yednock Ted
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
237
$29.96
$7.10K
Yednock Ted
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
5,680
$29.21
$165.91K
Yednock Ted
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
10,258
$28.54
$292.76K
Keswani Sanjay Chandru
24 Mar 2021
EVP & Chief Medical Officer
Sold after exercise
3,995
$30.17
$120.51K
Lew Jennifer
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,800
$29.16
$52.49K
Lew Jennifer
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,800
$28.43
$51.17K
Lew Jennifer
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,400
$27.51
$38.51K
Flynn James E
28 Jul 2020
10% owner
Buy indirect
350,000
$17.00
$5.95M
Flynn James E
28 Jul 2020
10% owner
Buy indirect
350,000
$17.00
$5.95M
Satter Muneer A
28 Jul 2020
Director
Buy indirect
200,000
$17.00
$3.40M
Lew Jennifer
28 Jul 2020
EVP & Chief Financial Officer
Buy
2,000
$17.00
$34.00K
Bain Capital Life Sciences Investors, LLC
28 Jul 2020
10% owner
Buy indirect
400,000
$17.00
$6.80M
Clarus Lifesciences III, L.P.
28 Jul 2020
10% owner
Buy indirect
200,000
$17.00
$3.40M

What was left out

Form 4 filings counted 171
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 25
Sales at will 39
Transactions with no price 0
Shares from compensation/vesting 10,927,333
Sales filed before the plan box existed 5
History held since 24 Jul 2020